JAK2 and Miyoshi myopathy: Further data supporting more selective JAK inhibitors were presented by Scuto, et al. who demonstrated that the selective JAK2 inhibitor AZD1480 was able to inhibit STAT3 phosphorylation and induce apoptosis in MM cell lines as well as in PDX [75].